NTNB Scan Service

The 11-14 weeks pregnancy ultrasound, also known as the first trimester screening or nuchal translucency (NT) scan, is a crucial scan that can provide important information about the developing fetus and assess the risk of certain chromosomal abnormalities.

Some of the key benefits of the 11-14 weeks pregnancy ultrasound include:

• Assessing fetal health: The 11-14 weeks ultrasound scan can assess the fetal health and development, including measuring the size of the fetus, checking the fetal heartbeat, and identifying any visible structural abnormalities.
• Measuring nuchal translucency: The scan can measure the thickness of the nuchal translucency, which is a small fluid-filled space at the back of the fetus’s neck. An increased nuchal translucency can be a sign of Down syndrome or other chromosomal abnormalities.
• Screening for chromosomal abnormalities: The 11-14 weeks ultrasound scan, when combined with a maternal blood test, can provide a risk assessment for certain chromosomal abnormalities, such as Down syndrome, Edwards syndrome, and Patau syndrome.
• Identifying multiple pregnancies: The scan can detect multiple pregnancies, such as twins or triplets.

• Establishing a baseline for future scans: The 11-14 weeks ultrasound scan can establish a baseline for future scans and provide important information for the healthcare provider to monitor fetal growth and development throughout the pregnancy.

The 11-14 weeks pregnancy ultrasound is a critical scan that can help healthcare providers assess the health and development of the fetus, identify potential chromosomal abnormalities, and provide important information for monitoring the pregnancy going forward. It is important to note that the results of the scan are only a screening test and do not provide a definitive diagnosis. Further testing may be recommended for women who receive a high-risk result.